Simona F Shaitelman, M.D., Ed.M.

Peer-Reviewed Articles

1. Tamirisa, N, Dong, W, Shen, Y, Lin, Y, Shaitelman, SF, Babiera, G, Bedrosian, I. Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer. npj Breast Cancer 11(1), 2025. e-Pub 2025. PMID: 39987164.
2. Reddy, JP, Sherry, AD, Fellman, B, Liu, S, Bathala, TK, Haymaker, CL, Cohen, L, Smith, B, Ramirez, DL, Shaitelman, SF, Chun, SG, Medina-Rosales, M, Teshome, M, Brewster, A, Barcenas, CH, Reuben, A, Ghia, AJ, Ludmir, EB, Weed, D, Shah, SJ, Mitchell, MP, Woodward, W, Gomez, D, Tang, C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND). International Journal of Radiation Oncology Biology Physics 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
3. Baroudi, H, Che Fru, L, Schofield, D, Roniger, DL, Nguyen, C, Hancock, D, Chung, CV, Beadle, BM, Gifford, KA, Netherton, T, Niedzielski, JS, Melancon, AD, Muruganandham, M, Khan, M, Shaitelman, SF, Shete, S, Murina, P, Venencia, D, Thengumpallil, S, Vrieling, C, Zhang, J, Mitchell, MP, Court, LE. An automated treatment planning portfolio for whole breast radiotherapy. Medical physics 52(3):1779-1788, 2025. e-Pub 2025. PMID: 39699058.
4. Baroudi, H, Che Fru, L, Schofield, D, Roniger, DL, Nguyen, C, Hancock, D, Chung, CV, Beadle, BM, Gifford, KA, Netherton, T, Niedzielski, JS, Melancon, AD, Muruganandham, M, Khan, M, Shaitelman, SF, Shete, S, Murina, P, Venencia, D, Thengumpallil, S, Vrieling, C, Zhang, J, Mitchell, MP, Court, LE. An automated treatment planning portfolio for whole breast radiotherapy. Medical physics 52(3):1779-1788, 2025. e-Pub 2025. PMID: 39699058.
5. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC. Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection. Communications Medicine 4(1), 2024. e-Pub 2024. PMID: 38796532.
6. Poli, E, Dong, W, Shaitelman, SF, Tamirisa, N, Shen, Y, Bedrosian, I. Survival outcomes after omission of surgery for ductal carcinoma in situ. npj Breast Cancer 10(1), 2024. e-Pub 2024.
7. Ben Kacem, M, Bright, SJ, Moran, E, Flint, DB, Martinus, DK, Turner, B, Qureshi, I, Kolachina, RV, Manandhar, M, Marinello, P, Shaitelman, SF, Sawakuchi, GO. PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 39730675.
8. Corrigan, KL, Bankston, ME, Holliday, EB, Shaitelman, SF, Lee, A, Goodman, C, Fuller, C, Chino, F, Thomas, CR, Jagsi, R, Ludmir, EB. Disease Site Specialization in the Academic Radiation Oncology Workforce. International Journal of Radiation Oncology Biology Physics 120(4):936-939, 2024. e-Pub 2024. PMID: 38897359.
9. Bright, SJ, Manandhar, M, Flint, DB, Kolachina, RV, Kacem, MB, Martinus, DK, Turner, B, Qureshi, I, McFadden, CH, Marinello, P, Shaitelman, SF, Sawakuchi, GO. ATR inhibition radiosensitizes cells through augmented DNA damage and G2 cell cycle arrest abrogation. JCI Insight 9(19), 2024. e-Pub 2024. PMID: 39235982.
10. Wanis, KN, Kuerer, HM, Sun, SX, Hunt, KK, Glencer, AC, Teshome, M, Lucci, A, Weiser, R, Johnson, HM, Smith, B, Gutierrez, AM, Shaitelman, SF, Arun, BK. Clinical Outcomes for BRCA Pathogenic Variant Carriers with Breast Cancer Undergoing Breast Conservation. JAMA Network Open:e2418486, 2024. e-Pub 2024. PMID: 38916888.
11. Yoder AK, Xu T, Youssef P, DeSnyder SM, Marqueen K, Isales L, Lin R, Smith BD, Woodward WA, Stauder MC, Strom EA, Aldrich MB, Shaitelman SF. Association between symptom burden and early lymphatic abnormalities after regional nodal irradiation for breast cancer. Pract Radiat Oncol 14(3):e180-e189, 2024. e-Pub 2024. PMID: 37914083.
12. Shaitelman, SF, Anderson, BM, Arthur, D, Bazan, JG, Bellon, JR, Bradfield, L, Coles, CE, Gerber, NK, Kathpal, M, Kim, L, Laronga, C, Meattini, I, Nichols, EM, Pierce, LJ, Poppe, M, Spears, PA, Vinayak, S, Whelan, T, Lyons, J. Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ. Practical radiation oncology 14(2):112-132, 2024. e-Pub 2024. PMID: 37977261.
13. Guhan M, Crane SM, Valerius LS, Cruz D, Smith BD, Woodward WA, Mitchell MP, Valero V, Rauch GM, Krishnamurthy S, Warnecke CL, Kuerer HM, Shaitelman SF. Patient interest in exploring non-surgical treatment approaches for early stage breast cancer: A qualitative study. Int J Radiat Oncol Biol Phys 118(2):443-454, 2024. e-Pub 2024. PMID: 37802228.
14. Baroudi H, Huy Minh Nguyen CI, Maroongroge S, Smith BD, Niedzielski JS, Shaitelman SF, Melancon A, Shete S, Whitaker TJ, Mitchell MP, Yvonne Arzu I, Duryea J, Hernandez S, El Basha D, Mumme R, Netherton T, Hoffman K, Court L. Automated contouring and statistical process control for plan quality in a breast clinical trial. Phys Imaging Radiat Oncol 28:100486, 2023. e-Pub 2023. PMID: 37712064.
15. Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Study Group ER. Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial. JAMA Netw Open 6(9):e2333933, 2023. e-Pub 2023. PMID: 37707811.
16. Shi JJ, Lei X, Chen YS, Chavez-MacGregor M, Bloom E, Schlembach P, Shaitelman SF, Buchholz TA, Kaiser K, Ku K, Smith BD, Smith GL. Socioeconomic Barriers to Randomized Clinical Trial Retention in Patients Treated With Adjuvant Radiation for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys 116(1):122-131, 2023. e-Pub 2023. PMID: 36724858.
17. Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
18. Vang AR, Shaitelman SF, Rasmussen JC, Chan W, Sevick-Muraca EM, Aldrich MB. Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765631.
19. Shen Y, Ning J, Lin HY, Shaitelman SF, Kuerer HM, Bedrosian I. Effectiveness Without Efficacy: Cautionary Tale from a Landmark Breast Cancer Randomized Controlled Trial. J Cancer 14(2):193-199, 2023. e-Pub 2023. PMID: 36741254.
20. Kuerer, HM, Smith, B, Shaitelman, SF, Krishnamurthy, S, Yang, WT, Valero, V, Shen, Y, Lin, Y, Lucci, A, Boughey, JC, White, RL, Diego, EJ, Rauch, GM, Moseley, T, van la Parra, RF, Adrada, BE, Leung, J, Sun, SX, Teshome, M, Miggins, MV, Hunt, KK, DeSnyder, SM, Ehlers II, RA, Hwang, RF, Colen, JS, Arribas, E, Samiian, L, Lesnikoski, BA, Piotrowski, MJ, Bedrosian, I, Chong, CD, Correa Refinetti, AP, Huang, ML, Candelaria, RP, Loveland-Jones, C, Mitchell, MP. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy. The lancet oncology 23(12):1517-1524, 2022. e-Pub 2022. PMID: 36306810.
21. Corrigan KL, Kouzy R, Jaoude JA, Patel RR, Layman RM, Giordano SH, Woodward WA, Smith BD, Shaitelman SF, Ludmir EB. Inclusion of premenopausal women in breast cancer clinical trials. Breast 66:204-207, 2022. e-Pub 2022. PMID: 36327626.
22. Anderson, BM, Arthur, D, Hannoun-Levi, JM, Kamrava, M, Khan, AJ, Kuske, R, Scanderbeg, DJ, Shah, C, Shaitelman, SF, Showalter, TN, Vicini, FA, Wazer, DE, Yashar, CM. Partial breast irradiation. Brachytherapy 21(6):726-747, 2022. e-Pub 2022. PMID: 36117086.
23. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6379-6380, 2022. e-Pub 2022. PMID: 36030283.
24. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6370-6378, 2022. e-Pub 2022. PMID: 35854031.
25. Bright SJ, Flint DB, Martinus DKJ, Turner BX, Manandhar M, Kacem MB, McFadden CH, Yap TA, Shaitelman SF, Sawakuchi GO. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons. Radiat Res 198(4):336-346, 2022. e-Pub 2022. PMID: 35939823.
26. Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 195(1):33-41, 2022. e-Pub 2022. PMID: 35816269.
27. Flint DB, Ruff CE, Bright SJ, Yepes P, Wang Q, Manandhar M, Kacem MB, Turner BX, Martinus DKJ, Shaitelman SF, Sawakuchi GO. An empirical model of proton RBE based on the linear correlation between x-ray and proton radiosensitivity. Med Phys 49(9):6221-6236, 2022. e-Pub 2022. PMID: 35831779.
28. Andring LM, Diao K, Sun S, Patel M, Whitman GJ, Schlembach P, Arzu I, Joyner MM, Shaitelman SF, Hoffman K, Stauder MC, Smith BD, Woodward WA. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement. Int J Radiat Oncol Biol Phys 113(3):552-560, 2022. e-Pub 2022. PMID: 35248602.
29. Manandhar M, Bright SJ, Flint DB, Martinus DKJ, Kolachina RV, Kacem MB, Titt U, Martin TJ, Lee CL, Morrison K, Shaitelman SF, Sawakuchi G. Effect of boron compounds on the biological effectiveness of proton therapy. Med Phys 49(9):6098-6109, 2022. e-Pub 2022. PMID: 35754208.
30. Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, Hoffman KE, Smith GL, Jagsi R, Peterson SK, Smith BD. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg 157(6):e220631, 2022. e-Pub 2022. PMID: 35416926.
31. Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2022. e-Pub 2022. PMID: 35387420.
32. Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. Int J Radiat Oncol Biol Phys 112(2):426-436, 2022. e-Pub 2022. PMID: 34610390.
33. Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. Int J Radiat Oncol Biol Phys 112(2):437-444, 2022. e-Pub 2022. PMID: 34582940.
34. Nowakowska MK, Lei X, Thompson MT, Shaitelman SF, Wehner MR, Woodward WA, Giordano SH, Nead KT. Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer 127(22):4142-4150, 2021. e-Pub 2021. PMID: 34342892.
35. Swanick CW, Jiang J, Maldonado JA, Lei X, Shih YT, Caudle AS, Baumann DP, Giordano SH, Shaitelman SF, Shirvani SM, Smith BD. Differences in Time Burden across Local Therapy Strategies for Early-stage Breast Cancer. Plast Reconstr Surg Glob Open 9(11):e3904, 2021. e-Pub 2021. PMID: 34745797.
36. Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
37. Shah C, Jia X, Hobbs BP, Tendulkar RD, Sittenfeld SMC, Al-Hilli Z, Arthur DW, Keisch ME, Khan AJ, Shaitelman SF, Boyages J, Wazer D, Kundu N, Vicini FA. Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis. Ann Surg Oncol 28(9):4985-4994, 2021. e-Pub 2021. PMID: 33393051.
38. Tamirisa N, Lin H, Shen Y, Shaitelman SF, Karuturi MS, Giordano SH, Babiera GV, Bedrosian I. Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis. Cancer 127(13):2196-2203, 2021. e-Pub 2021. PMID: 33735487.
39. Boyce-Fappiano D, Bedrosian I, Shen Y, Lin H, Gjyshi O, Yoder A, Shaitelman SF, Woodward WA. Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis. NPJ Breast Cancer 7(1):87, 2021. e-Pub 2021. PMID: 34226566.
40. Flint DB, Bright SJ, McFadden CH, Konishi T, Ohsawa D, Turner B, Lin SH, Grosshans DR, Chiu HS, Sumazin P, Shaitelman SF, Sawakuchi GO. Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions. Med Phys 48(6):3243-3261, 2021. e-Pub 2021. PMID: 33837540.
41. Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, Kumar T, Hu M, Sei E, Davis A, Wang F, Shaitelman SF, Wang JR, Chen K, Moulder S, Lai SY, Navin NE. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol 39(5):599-608, 2021. e-Pub 2021. PMID: 33462507.
42. Lim B, Song J, Ibrahim NK, Koenig KB, Chavez-MacGregor M, Ensor JE, Gomez JS, Krishnamurthy S, Caudle AS, Shaitelman SF, Whitman GJ, Valero V. A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer. Oncologist 26(2):e230-e240, 2021. e-Pub 2021. PMID: 33140515.
43. Pasalic D, Strom EA, Allen PK, Williamson TD, Poenisch F, Amos RA, Woodward WA, Stauder MC, Shaitelman SF, Smith BD, Perkins GH, Tereffe W, Hoffman KE. Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys 109(2):441-448, 2021. e-Pub 2021. PMID: 32946965.
44. Paganetti H, Beltran CJ, Both S, Dong L, Flanz JB, Furutani KM, Grassberger C, Grosshans DR, Knopf AC, Langendijk JA, Nyström H, Parodi K, Raaymakers BW, Richter C, Sawakuchi GO, Schippers JM, Shaitelman SF, Teo K, Unkelbach J, Wohlfahrt P, Lomax AJ. Roadmap: proton therapy physics and biology. Phys Med Biol 66(5), 2021. e-Pub 2021. PMID: 33227715.
45. Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther 8(1):374-382, 2021. e-Pub 2021. PMID: 34285963.
46. Coroneos CJ, Woodward WA, Wong FC, Caudle AS, Shaitelman SF, Kuerer HM, Schaverien MV. Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer. J Surg Oncol 123(4):846-853, 2020. e-Pub 2020. PMID: 33333583.
47. Vasmel JE, Groot Koerkamp ML, Kirby AM, Russell NS, Shaitelman SF, Vesprini D, Anandadas CN, Currey A, Keller BM, Braunstein LZ, Han K, Kotte AN, de Waard SN, Philippens ME, Houweling AC, Verkooijen HM, van den Bongard HD. Consensus on contouring primary breast tumors on MRI in the setting of neoadjuvant partial breast irradiation in trials. Pract Radiat Oncol 10(6):e466-3474, 2020. e-Pub 2020. PMID: 32315784.
48. Tamirisa N, Lin H, Shen Y, Shaitelman SF, Sri Karuturi M, Giordano SH, Babiera G, Bedrosian I. Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer. JAMA Oncol 6(10):1548-1554, 2020. e-Pub 2020. PMID: 32672820.
49. Chapman BV, Lei X, Patil P, Tripathi S, Nicklaus KM, Grossberg AJ, Shaitelman SF, Thompson AM, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD, Reddy JP. Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. Adv Radiat Oncol 5(5):824-833, 2020. e-Pub 2020. PMID: 33083644.
50. Shaitelman SF, Jeruss JS, Pusic AL. Oncoplastic Surgery in the Management of Breast Cancer. J Clin Oncol 38(20):2246-2253, 2020. e-Pub 2020. PMID: 32442070.
51. Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
52. Casal RF, Schwalk AJ, Fowlkes N, Aburto RR, Norton W, Dixon KA, Lin S, Shaitelman SF, Chintalapani G, Hill L. Endobronchial ultrasound-guided injection of NBTXR3 radio-enhancing nanoparticles into mediastinal and hilar lymph nodes: a swine model to evaluate feasibility, injection technique, safety, nanoparticle retention and dispersion. J Thorac Dis 12(5):2317-2324, 2020. e-Pub 2020. PMID: 32642136.
53. Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol 27(4):1013-1022, 2020. e-Pub 2020. PMID: 31916092.
54. Esho TO, Chung CV, Thompson JU, Dehghanpour M, Sutton JR, Shaitelman SF, Kisling KK, Court LE. Optimization of autogenerated chest-wall radiation treatment plans developed for postmastectomy breast cancer patients in underserved clinics. Med Dosim 45(1):102-107, 2020. e-Pub 2020. PMID: 31956001.
55. Moreno AC, Lin YH, Bedrosian I, Shen Y, Babiera GV, Shaitelman SF. Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes. J Cancer 11(6):1341-1350, 2020. e-Pub 2020. PMID: 32047541.
56. Buszek SM, Shaitelman SF. In Reply to Braunstein. Int J Radiat Oncol Biol Phys 105(5):1162-1163, 2019. e-Pub 2019. PMID: 31748138.
57. Bright SJ, Flint DB, Chakraborty S, McFadden CH, Yoon DS, Bronk L, Titt U, Mohan R, Grosshans DR, Sumazin P, Shaitelman SF, Asaithamby A, Sawakuchi GO. Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death. Int J Radiat Oncol Biol Phys 105(5):1119-1125, 2019. e-Pub 2019. PMID: 31425731.
58. Raber BM, Lin H, Shen Y, Shaitelman SF, Bedrosian I. Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden. Ann Surg Oncol 26(13):4346-4354, 2019. e-Pub 2019. PMID: 31605340.
59. Kwon S, Janssen CF, Velasquez FC, Zhang S, Aldrich MB, Shaitelman SF, DeSnyder SM, Sevick-Muraca EM. Radiation Dose-Dependent Changes in Lymphatic Remodeling. Int J Radiat Oncol Biol Phys 105(4):852-860, 2019. e-Pub 2019. PMID: 31394167.
60. Buszek SM, Lin HY, Bedrosian I, Tamirisa N, Babiera GV, Shen Y, Shaitelman SF. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database. Int J Radiat Oncol Biol Phys 105(4):795-802, 2019. e-Pub 2019. PMID: 31377160.
61. Kisling K, Zhang L, Shaitelman SF, Anderson D, Thebe T, Yang J, Balter PA, Howell RM, Jhingran A, Schmeler K, Simonds H, du Toit M, Trauernicht C, Burger H, Botha K, Joubert N, Beadle BM, Court L. Automated treatment planning of postmastectomy radiotherapy. Med Phys 46(9):3767-3775, 2019. e-Pub 2019. PMID: 31077593.
62. DeSnyder SM, Kheirkhah P, Travis ML, Lilly SE, Bedrosian I, Buchholz TA, Schaverien MV, Shaitelman SF. Optimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema. Lymphat Res Biol 17(4):440-446, 2019. e-Pub 2019. PMID: 30562149.
63. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy 18(4):445-452, 2019. e-Pub 2019. PMID: 30992185.
64. Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle AS, Hunt KK, Hwang RF. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes. Breast Cancer Res Treat 176(2):435-444, 2019. e-Pub 2019. PMID: 31025270.
65. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
66. Coroneos CJ, Wong FC, DeSnyder SM, Shaitelman SF, Schaverien MV. Correlation of L-Dex Bioimpedance Spectroscopy with Limb Volume and Lymphatic Function in Lymphedema. Lymphat Res Biol 17(3):301-307, 2019. e-Pub 2019. PMID: 30388062.
67. Stecklein SR, Shaitelman SF. In Reply to Mailhot et al. Int J Radiat Oncol Biol Phys 103(5):1281, 2019. e-Pub 2019. PMID: 30900563.
68. Stecklein SR, Shaitelman SF, Babiera GV, Bedrosian I, Black DM, Ballo MT, Arzu I, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE, Schlembach PJ, Kirsner SM, Nelson CL, Yang J, Guerra W, Dibaj S, Bloom ES. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Pract Radiat Oncol 9(1):e4-e13, 2019. e-Pub 2019. PMID: 30125673.
69. Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 4(12):1751-1757, 2018. e-Pub 2018. PMID: 30027292.
70. Stecklein SR, Park M, Liu DD, Valle Goffin JJ, Caudle AS, Mittendorf EA, Barcenas CH, Mougalian S, Woodward WA, Valero V, Sahin AA, Yang WT, Shaitelman SF. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy. Int J Radiat Oncol Biol Phys 102(3):568-577, 2018. e-Pub 2018. PMID: 29928946.
71. Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol 36(35):3495-3503, 2018. e-Pub 2018. PMID: 30379626.
72. Weiss A, Chu CK, Lin H, Shen Y, Shaitelman SF, Garvey PB, Bedrosian I, Babiera GV. Reconstruction in the Metastatic Breast Cancer Patient: Results from the National Cancer Database. Ann Surg Oncol 25(11):3125-3133, 2018. e-Pub 2018. PMID: 30109538.
73. Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol 3(3):252-257, 2018. e-Pub 2018. PMID: 30197937.
74. Weiss A, Menen RS, Lin HY, Shen Y, Rosso KJ, Shaitelman S, Woodward W, Valero V, Ueno NT, Bedrosian I, Babiera G. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Res Treat 169(3):615-623, 2018. e-Pub 2018. PMID: 29460033.
75. Netherton T, Li Y, Nitsch P, Shaitelman S, Balter P, Gao S, Klopp A, Muruganandham M, Court L. Interplay effect on a 6-MV flattening-filter-free linear accelerator with high dose rate and fast multi-leaf collimator motion treating breast and lung phantoms. Med Phys 45(6):2369-2376, 2018. e-Pub 2018. PMID: 29611210.
76. Ovalle V, Strom EA, Shaitelman S, Hoffman K, Amos R, Perkins G, Tereffe W, Smith BD, Stauder M, Woodward W. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers (Basel) 10(4), 2018. e-Pub 2018. PMID: 29642467.
77. Brunelle CL, Barrio AV, Shaitelman SF, Singhal D, Sayegh HE, Taghian AG. On "Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline from the Oncology Section of the American Physical Therapy Association." Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L. Phys Ther. 2017;97:729-745. Phys Ther 98(4):277-281, 2018. e-Pub 2018. PMID: 29617972.
78. Court LE, Kisling K, McCarroll R, Zhang L, Yang J, Simonds H, du Toit M, Trauernicht C, Burger H, Parkes J, Mejia M, Bojador M, Balter P, Branco D, Steinmann A, Baltz G, Gay S, Anderson B, Cardenas C, Jhingran A, Shaitelman S, Bogler O, Schmeller K, Nelson C, Peterson C, Beadle B Followill D, Howell R. Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System. J Vis Exp(134), 2018. e-Pub 2018. PMID: 29708544.
79. Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study. Int J Radiat Oncol Biol Phys 100(4):882-890, 2018. e-Pub 2018. PMID: 29485067.
80. Shah C, Vicini F, Shaitelman SF, Hepel J, Keisch M, Arthur D, Khan AJ, Kuske R, Patel R, Wazer DE. The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation. Brachytherapy 17(1):154-170, 2018. e-Pub 2018. PMID: 29074088.
81. Alexander A, Arnold TL, Bishnoi S, Ballinger C, Shaitelman SF, Schaverien MV, Cohen L, Dev M, Ueno NT. Survivorship and Advocacy in Inflammatory Breast Cancer. J Cancer 9(8):1430-1436, 2018. e-Pub 2018. PMID: 29721053.
82. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol 24(10):2965-2971, 2017. e-Pub 2017. PMID: 28766219.
83. Moreno AC, Shaitelman SF, Buchholz TA. A clinical perspective on regional nodal irradiation for breast cancer. Breast 34 Suppl 1:S85-S90, 2017. e-Pub 2017. PMID: 28690104.
84. Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SF. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol 2(3):291-300, 2017. e-Pub 2017. PMID: 29114595.
85. Lin HY, Bedrosian I, Babiera GV, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen Y. Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer. Cancer 123(14):2618-2625, 2017. e-Pub 2017. PMID: 28295213.
86. Shaitelman SF, Howell RM, Smith BD. Effects of Smoking on Late Toxicity From Breast Radiation. J Clin Oncol 35(15):1633-1635, 2017. e-Pub 2017. PMID: 28319432.
87. Shaitelman SF, Chiang YJ, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, Woodward WA, Cormier JN. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat 162(2):201-215, 2017. e-Pub 2017. PMID: 28012086.
88. Shaitelman SF, Chiang YJ, Griffin KD, De Snyder SM, Smith BD, Schaverien MV, Woodward WA, Cormier JN. Erratum to: Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat 162(2):217, 2017. e-Pub 2017. PMID: 28185145.
89. Reddy JP, Lei X, Huang SC, Nicklaus KM, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD. Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 97(5):894-902, 2017. e-Pub 2017. PMID: 28333010.
90. Wilkinson JB, Shah C, Amin M, Nadeau L, Shaitelman SF, Chen PY, Grills IS, Martinez AA, Mitchell CK, Wallace MF, Vicini FA. Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation. Clin Breast Cancer 17(1):55-60, 2017. e-Pub 2017. PMID: 27666436.
91. Mitchell KB, Lin H, Shen Y, Colfry A, Kuerer H, Shaitelman SF, Babiera GV, Bedrosian I. DCIS and axillary nodal evaluation: compliance with national guidelines. BMC Surg 17(1):12, 2017. e-Pub 2017. PMID: 28173790.
92. Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and complications of local therapies for early stage breast cancer. J Natl Cancer Inst 109(1), 2017. e-Pub 2017. PMID: 27678203.
93. Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, Reddy J, Amaya D, Guerra W, Ueno N, Caudle A, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer 8(11):2026-2032, 2017. e-Pub 2017. PMID: 28819403.
94. Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-44, 2016. e-Pub 2016. PMID: 27681760.
95. Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret MC, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak T, Thompson AM, Buchholz TA, Smith BD. Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation. Cancer 122(18):2886-94, 2016. e-Pub 2016. PMID: 27305037.
96. Thrower SL, Shaitelman SF, Bloom E, Salehpour M, Gifford K. Comparison of Dose Distributions With TG-43 and Collapsed Cone Convolution Algorithms Applied to Accelerated Partial Breast Irradiation Patient Plans. Int J Radiat Oncol Biol Phys 95(5):1520-1526, 2016. e-Pub 2016. PMID: 27315666.
97. Loveland-Jones C, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, Woodward W, Ueno N, Valero V, Babiera G. Disparities in the use of postmastectomy radiation therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 95(4):1218-25, 2016. e-Pub 2016. PMID: 27209502.
98. Shirvani SM, Jiang J, Likhacheva A, Hoffman KE, Shaitelman SF, Caudle A, Buchholz TA, Giordano SH, Smith BD. Trends in local therapy utilization and cost for early-stage breast cancer in older women: Implications for payment and policy reform. Int J Radiat Oncol Biol Phys 95(2):605-16, 2016. e-Pub 2016. PMID: 27034179.
99. Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE. Proton partial-breast irradiation for early-stage cancer: Is it really so costly?. Int J Radiat Oncol Biol Phys 95(1):49-51, 2016. e-Pub 2016. PMID: 27084625.
100. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
101. Pan HY, Shaitelman SF, Perkins GH, Schlembach PJ, Woodward WA, Smith BD. Implementing a real-time electronic data capture system to improve clinical documentation in radiation oncology. J Am Coll Radiol 13(4):S1546, 2016. e-Pub 2016. PMID: 26681164.
102. Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EA. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol 23(3):749-56, 2016. e-Pub 2016. PMID: 26511263.
103. Huo J, Giordano SH, Smith BD, Shaitelman SF, Smith GL. Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer. Int J Radiat Oncol Biol Phys 94(4):709-718, 2016. e-Pub 2016. PMID: 26972643.
104. Shaitelman SF, Lin HY, Smith BD, Shen Y, Bedrosian I, Marsh GD, Bloom ES, Vicini FA, Buchholz TA, Babiera GV. Practical implications of the publication of consensus guidelines by the American Society for Radiation Oncology: accelerated partial breast irradiation and the National Cancer Data Base. Int J Radiat Oncol Biol Phys 94(1):338-348, 2016. e-Pub 2016. PMID: 26853342.
105. Voss RK, Cromwell KD, Chiang YJ, Armer JM, Ross MI, Lee JE, Gershenwald JE, Stewart BR, Shaitelman SF, Cormier JN. The long-term risk of upper-extremity lymphedema is two-fold higher per lymph node removed in breast cancer patients than in melanoma patients. J Surg Oncol 112(8):834-40, 2015. e-Pub 2015. PMID: 26477877.
106. Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE, Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer 121(24):4324-32, 2015. e-Pub 2015. PMID: 26348887.
107. Grant SR, Walker GV, Koshy M, Shaitelman SF, Klopp AH, Frank SJ, Pugh TJ, Allen PK, Mahmood U. Impact of insurance status on radiation treatment modality selection among potential candidates for prostate, breast or gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 93(5):968-75, 2015. e-Pub 2015. PMID: 26452570.
108. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol 1(7):931-41, 2015. e-Pub 2015. PMID: 26247543.
109. Babiera G, Bedrosian I, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen Y. Factors influencing treatment of inflammatory breast cancer in the United States. J Clin Oncol 33(28_suppl):118, 2015. e-Pub 2015. PMID: 28147821.
110. Shah C, Vicini FA, Berry S, Julian TB, Wilkinson JB, Shaitelman SF, Khan A, Finkelstein SE, Goldstein N. Ductal carcinoma in situ of the breast: evaluating the role of radiation therapy in the management and attempts to identify low-risk patients. Am J Clin Oncol 38(5):526-33, 2015. e-Pub 2015. PMID: 25036472.
111. Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
112. Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, Babiera G, Bedrosian I. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg 150(8):778-86, 2015. e-Pub 2015. PMID: 26083835.
113. Strom EA, Amos RA, Shaitelman SF, Kerr MD, Hoffman KE, Smith BD, Tereffe W, Stauder MC, Perkins GH, Amin MD, Wang X, Poenisch F, Ovalle V, Buchholz TA, Babiera G, Woodward WA. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol 5(4):e283-90, 2015. e-Pub 2015. PMID: 25804105.
114. Wobb JL, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 91(2):312-318, 2015. e-Pub 2015. PMID: 25446607.
115. Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus 4:36, 2015. e-Pub 2015. PMID: 25674496.
116. Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch PD. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. J Clin Oncol 32(26_suppl):59, 2014. e-Pub 2014. PMID: 28141019.
117. Lin HY, Shen Y, Parker C, Kuerer HM, Shaitelman SF, Babiera G, Bedrosian I. Disparities in utilization of breast-conserving therapy among breast cancer patients. J Clin Oncol 32(26_suppl):104, 2014. e-Pub 2014. PMID: 28141132.
118. Lin HY, Shen Y, Li L, Lautner MA, Kuerer HM, Shaitelman SF, Babiera G, Bedrosian I. Effect of hormone receptor status and local treatment on overall survival for early-stage breast cancer. J Clin Oncol 32(26_suppl):60, 2014. e-Pub 2014. PMID: 28141094.
119. Shaitelman S, Buchholz TA, Hunt KK, Hortobagyi G, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, Grade Hoffman K, Perkins G, Reed V, Shah S, Stauder M, Strom E, Tereffe W, Woodward W, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irradiation: results of a randomized trial 90(5):1264, 2014. e-Pub 2014. PMID: 95539386.
120. Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the American College of Surgeons Oncology Group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
121. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation. Ann Surg Oncol 21(8):2512-2516, 2014. e-Pub 2014. PMID: 24736987.
122. Rueth NM, Lin HY, Bedrosian I, Shaitelman SF, Ueno NT, Shen Y, Babiera G. Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database. J Clin Oncol 32(19):2018-2024, 2014. e-Pub 2014. PMID: 24888808.
123. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiotherapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-122, 2014. e-Pub 2014. PMID: 24890352.
124. Shaitelman SF, Khan AJ, Woodward WA, Arthur DW, Cuttino LW, Bloom ES, Shah C, Freedman GM, Wilkinson JB, Babiera GV, Julian TB, Vicini FA. Shortened radiation therapy schedules for early stage breast cancer: A review of hypofractionated whole breast irradiation and accelerated partial breast irradiation. Breast J 20(2):131-46, 2014. e-Pub 2014. PMID: 24479632.
125. Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?. Br J Radiol 86(1029):20130176, 2013. e-Pub 2013. PMID: 23728947.
126. Vicini FA, Shaitelman S, Wilkinson JB, Shah C, Ye H, Kestin LL, Goldstein NS, Chen PY, Martinez AA. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy. Breast J 19(4):365-73, 2013. e-Pub 2013. PMID: 23815268.
127. Wilkinson JB, Beitsch PD, Shah C, Arthur D, Haffty BG, Wazer DE, Keisch M, Shaitelman SF, Lyden M, Chen PY, Vicini FA. Evaluation of Current Consensus Statement Recommendations for Accelerated Partial Breast Irradiation: A Pooled Analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite(®) Registry Trial Data. Int J Radiat Oncol Biol Phys 85(5):1179-85, 2013. e-Pub 2013. PMID: 23182700.
128. Wilkinson JB, Vicini FA, Shah C, Shaitelman S, Jawad MS, Ye H, Kestin LL, Goldstein NS, Martinez AA, Benitez P, Chen PY. Twenty-Year Outcomes after Breast-Conserving Surgery and Definitive Radiotherapy for Mammographically Detected Ductal Carcinoma In Situ. Ann Surg Oncol 19(12):3785-91, 2012. e-Pub 2012. PMID: 22644510.
129. Shaitelman SF, Wilkinson JB, Kestin LL, Ye H, Goldstein NS, Martinez AA, Vicini FA. Long-Term Outcome in Patients with Ductal Carcinoma in situ Treated with Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies. Int J Radiat Oncol Biol Phys 83(3):e305-12, 2012. e-Pub 2012. PMID: 22417804.
130. Shah C, Wilkinson JB, Shaitelman S, Grills IS, Chen PY, Dekhne N, Jaiyesimi I, Wallace M, Mitchell CK, Vicini FA. Impact of Lymph Node Status on Clinical Outcomes After Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 82(3):e409-14, 2012. e-Pub 2012. PMID: 21944464.
131. Shaitelman SF, Vicini FA, Grills IS, Martinez AA, Yan D, Kim LH. Differences in Effective Target Volume Between Various Techniques of Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 82(1):30-6, 2012. e-Pub 2012. PMID: 21050674.
132. Shaitelman SF, Grills IS, Kestin LL, Ye H, Nandalur S, Huang J, Vicini FA. Rates of Second Malignancies After Definitive Local Treatment for Ductal Carcinoma In Situ of the Breast. Int J Radiat Oncol Biol Phys 81(5):1244-51, 2011. e-Pub 2011. PMID: 21030159.
133. Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Int J Radiat Oncol Biol Phys 81(4):e547-541, 2011. e-Pub 2011. PMID: 21640491.
134. Shaitelman SF, Kim LH, Grills IS, Chen PY, Ye H, Kestin LL, Yan D, Vicini FA. Predictors of Long-Term Toxicity Using Three-Dimensional Conformal External Beam Radiotherapy To Deliver Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 81(3):788, 2011. e-Pub 2011. PMID: 20933342.
135. Wilkinson JB, Reid RE, Shaitelman SF, Chen PY, Mitchell CK, Wallace MF, Marvin KS, Grills IS, Margolis JM, Vicini FA. Outcomes of Breast Cancer Patients With Triple Negative Receptor Status Treated With Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 81(3):S227-S228, 2011. e-Pub 2011. PMID: 21345613.
136. Shaitelman SF, Kim LH, Yan D, Martinez AA, Vicini FA, Grills IS. Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis. Int J Radiat Oncol Biol Phys 80(3):771-8, 2011. e-Pub 2011. PMID: 20584586.
137. Beitsch P, Vicini F, Keisch M, Haffty B, Shaitelman S, Lyden M. Five-year outcome of patients classified in the "unsuitable" category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite® Registry trial. Ann Surg Oncol 17 Suppl 3:219-25, 2010. e-Pub 2010. PMID: 20853036.
138. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer 116(20):4677-85, 2010. e-Pub 2010. PMID: 20602483.

Invited Articles

1. Moreno AC, vShaitelman SF, Buchholz TA. A clinical perspective on regional nodal irradiation for breast cancer. Breast 34(Suppl1):S85-S90, 2017. e-Pub 2017. PMID: 28690104.
2. Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 65(1):55-81, 2015. e-Pub 2015. PMID: 25410402.
3. Shaitelman SF, Kim LH. Accelerated partial-breast irradiation: The current state of our knowledge. Oncology (Williston Park) 27(4):329-42, 2013. e-Pub 2013. PMID: 23781698.
4. Beitsch PD, Shaitelman SF, Vicini FA. Accelerated partial breast irradiation. J Surg Oncol 103(4):362-8, 2011. e-Pub 2011. PMID: 21337572.
5. Théberge V, Whelan T, Shaitelman SF, Vicini FA. Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. Semin Radiat Oncol 21(1):55-65, 2011. e-Pub 2011. PMID: 21134655.
6. Shaitelman SF, Vicini FA. Status of accelerated partial breast irradiation. Curr Breast Cancer Rep 2:59-66, 2010. e-Pub 2010.

Manuals, Teaching Aids, Other Teaching Publications

1. Shaitelman SF. Patient Education, Lymphedema Screening for Breast Cancer Patients. Patient Education Office, The University of Texas MD Anderson Cancer Center, 2015.

Other Articles

1. Ohannesian, N, Mallick, MS, He, J, Qiao, Y, Li, N, Shaitelman, SF, Tang, C, Shinn, EH, Hofstetter, WL, Goltsov, A, Hassan, MM, Hunt, KK, Lin, SH, Shih, WC Author Correction: Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detection (Communications Medicine, (2024), 4, 1, (100), 10.1038/s43856-024-00514-x). Communications Medicine 4(1), 2024. PMID: 38942807.
2. Shaitelman, SF, Woodward, W Neoadjuvant radioimmunotherapy synergy in triple-negative breast cancer. Cancer cell 42(1):10-12, 2024. PMID: 38194911.
3. De-Colle C, Kirby A, Russell N, Shaitelman SF, Currey A, Donovan E, Hahn E, Han K, Anandadas CN, Mahmood F, Lorenzen EL, van den Bongard D, Groot Koerkamp ML, Houweling AC, Nachbar M, Thorwarth D, Zips D Adaptive radiotherapy for breast cancer. Clin Transl Radiat Oncol 39:100564, 2023. PMID: 36632056.
4. Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM The Development and Treatment of Lymphatic Dysfunction in Cancer Patients and Survivors. Cancers (Basel) 12(8), 2020. PMID: 32823928.
5. Groot Koerkamp ML, Vasmel JE, Russell NS, Shaitelman SF, Anandadas CN, Currey A, Vesprini D, Keller BM, De-Colle C, Han K, Braunstein LZ, Mahmood F, Lorenzen EL, Philippens MEP, Verkooijen HM, Lagendijk JJW, Houweling AC, Bongard HJGD VD, Kirby AM Optimizing MR-Guided Radiotherapy for Breast Cancer Patients. Front Oncol 10:1107, 2020. PMID: 32850318.
6. Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, Sawakuchi GO, Shaitelman SF, Powell SN, Woodward WA The implications of genetic testing on radiotherapy decisions: a guide for radiation oncologists. Int J Radiat Oncol Biol Phys 105(4):698-712, 2019. PMID: 31381960.
7. Farooqi AS, Sun TL, Thang S, Shaitelman SF Treatment of bilateral breast cancer and regional nodes using an opposed lateral beam arrangement. Pract Radiat Oncol 7(6):e385-e389, 2017. PMID: 28867548.
8. Hepel JT, Arthur D, Shaitelman S, Polgár C, Todor D, Zoberi I, Kamrava M, Major T, Yashar C, Wazer DE American Brachytherapy Society consensus report for accelerated partial breast irradiation using interstitial multicatheter brachytherapy. Brachytherapy 16(5):919-928, 2017. PMID: 28676428.
9. Shaitelman SF, Amendola B, Khan A, Beriwal S, Rabinovitch R, Demanes DJ, Kim LH, Cuttino L American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer. Brachytherapy 16(1):13-21, 2017. PMID: 27288156.

Editorials

1. Shaitelman, SF. ABLATIVE Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology Biology Physics 121(3):623-625, 2025. PMID: 39909611.
2. Shaitelman SF. Lymphedema: Time for an Update. Int J Radiat Oncol Biol Phys 102(1):79-81, 2018. PMID: 30102207.
3. Stecklein SR, Shaitelman SF. Commentary on: DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node- Positive Breast Cancer. Breast Diseases: A Year Book Quarterly 27(3):211-213, 2016.
4. Shaitelman SF. Commentary On: Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer: Bains SK, Peters AM, Zammit C, et al (St George's, Univ of London, UK; Brighton and Sussex Univ Hosps NHS Trust, UK) Br J Surg 102:534-540,2015. Breast Diseases: a YB Quarterly 26(3):204-205, 2015.
5. Shaitelman SF. Commentary: Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation: Rodriguez N, Sanz X, Dengra J, et al (Hospital de la Esperanza, Barcelona, Spain) Int J Radiat Oncol Biol Phys 87:1051-1057, 2013. Breast Diseases: A Year Book Quarterly 25(2):160-161, 2014.
6. Shaitelman SF. Commentary: Randomized Trial of Pentoxifylline and Vitamin E vs Standard Follow-up After Breast Irradiation to Prevent Breast Fibrosis, Evaluated by Tissue Compliance Meter: Jacobson G, Bhatia S, Smith BJ, et al (University of Iowa Hospitals and Clinics, Iowa City) Int J Radiat Oncol Biol Phys 85:604-608, 2013. Breast Diseases Quarterly 24(3):278-279, 2013.
7. Shaitelman SF. Commentary on: Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer: Bevilacqua JLB, Kattan MW, Changhong Y et al (Escola Nacional de Saude Publica/FIOCRUZ, Rio de Janeiro, Brazil; Cleveland Clinic, OH; et al) Ann Surg Oncol 19:2580-2589, 2012. Breast Diseases: A Year Book Quarterly 24(2):159-160, 2013.
8. Shaitelman SF. Commentary on: Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation: Shah C, Wilkinson JB, Baschnagel A, et al (William Beaumont Hosp, Royal Oak, MI; et al) Int J Radiat Oncol Biol Phys 83:1095-1100, 2012. Breast Diseases: A Year Book Quarterly 23(4):371-372, 2013.
9. Shaitelman SF, Wagner JM. Commentary on: Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer: Bar Ad V, Dutta PR, Solin LJ, et al (Univ of Pennsylvania, Philadelphia) Breast J 18:219-225, 2012. Breast Diseases: A Year Book Quarterly 24(1):92-93, 2013.
10. Shaitelman SF. Commentary On: Increased rates of long-term complications after MammoSite brachytherapy compared with whole breast radiation therapy: Rosenkranz KM, Tsui E, McCabe EB, et al (Dartmouth Hitchcock Med Ctr, Lebanon, NH; Geisel Med School at Dartmouth, Hanover, NH; et al) J Am Coll Surg 217:497-502, 2013. Breast Diseases: A Year Book Quarterly 25(1):78-80, 2013.
11. Shaitelman SF. Commentary On: Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria: VanderWalde NA, Jones EL, Kimple RJ, et al (Univ of North Carolina at Chapel Hill; Univ of Wisconsin School of Medicine, Madison) Cancer 119:1736-1743, 2013. Breast Diseases: A Year Book Quarterly 24(4):388-389, 2013.
12. Shaitelman SF. Commentary on: Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features: McHaffie DR, Patel RR, Adkison JB, et al (Univ of Wisconsin School of Medicine and Public Health, Madison; Western Radiation Oncology, Mountain View, CA) Int J Radiat Oncol Biol Phys 81:46-51, 2011. Breast Diseases: A Year Book Quarterly 23(1):86-87, 2012.
13. Shaitelman SF. Sounding a warning bell? Documentation of the increased utilization of accelerated partial breast irradiation. J Natl Cancer Inst 104(1):5-7, 2012. PMID: 22180644.

Abstracts

1. Shaitelman SF, Gandhi A, DeSnyder S, Smith GL, Lin R, Barcenas C, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward BS, Perkins GH, Mitchell MP, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I. Prospective, Longitudinal Assessment of Lymphedema-related Quality of Life for Locally Advanced Breast Cancer Patients: A Foundation for Needed Elements in a Lymphedema Screening Program, 2022. e-Pub 2022.
2. Andring LM, Diao K, Sun SX, Patel MM, Schlembach PJ, Arzu IA, Joyner MM, Shaitelman SF, Hoffman KE, Stauder MC, Smith MC, Smith BD, Woodward WA. Prognostic Factors in Breast Cancer Patients with Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease 111(3):E195-1965, 2021. e-Pub 2021.
3. Reddy JP, Lei X, Bloom E, Reed VK, Schlembach PJ, Arzu IY, Gopal RS, Mayo LL, Chun SG, Ahmad NR, Stauder MC, Chronowski GM, Weed DW, Delclos MEE, Garge AK, Shaitelman SF, Fang P, Tereffe W, Woodward WA, Smith BD. Optimizing Preventive Adjuvant LINAL (OPAL) Radiation: A Phase II Trial of Daily Partial Breast Irradiation 111(3):S108-109, 2021. e-Pub 2021.
4. Bright SJ, Flint DB, Turner BX, Mandadhar M, McFadden CH, Martinus D, Ben Kacem M, Sawakuchi G, Shaitelman SF. Inhibiting ATR Modulates Response to Radiation and Stimulates Immune Responses 111(3):S69-70, 2021. e-Pub 2021.
5. Bright SJ, Flint DB, Turner BX, Mandadhar M, McFadder CH, Martinus D, Ben Kacem M, Shaitelman SF, Sawakuchi G. DNA Damage Response Inhibitors of DNA-PKcs, PARP, RAD51, ATR and ATM All Sensitize Cancer Cells to X-Rays and Protons 111(3):e230, 2021. e-Pub 2021.
6. Boyce-Fappiano D, Bedrosian I, Shen Y, Lin HY, Gjyshi O, Yoder AK, Shaitelman SF, Woodward WA. Evaluation of Overall Survival and Barriers to Surgery for Breast Cancer Patients Treated Without Surgery 111(3):e320-321, 2021. e-Pub 2021.
7. Doughtie K, Shaitelman SF, Stauder MC, Lopez-Varon M, Baker E, Salcedo MP, Phoolcharoen N, Daheri M, Rabel K, Schmeler K. The Role of Nurse Practitioners in Global Cancer Care 108(3):S80-S81, 2020. e-Pub 2020.
8. Garner D, DeSnyder SM, Isales L, Woodward WA, Colbert L, Strom EA, Smith BD, Stauder MC, Aldrich M, Shaitelman SF. Baseline Inflammatory Markers Are Associated with Upper Extremity Lymphedema in Breast Cancer Patients 108(3):E542-543, 2020. e-Pub 2020.
9. Shaitelman, SF. Guiding selection of RT approach after lumpectomy 80(4), 2020. e-Pub 2020.
10. White JR, Winter K, Cecchini RS, Vicini FA, Arthur DW, Kuske RR, Rabinovitch RA, Sehkon A, Khan AJ, Chmura SJ, Shaitelman SF, McCormick B, Julian TB, Rogers CL, Bear HD, Petersen IA, Gustafson GS, Grossheim LD, Mamounas E, Ganz PA. Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39- RTOG 0413 Phase III Clinical Trial 105(1):S3-S4, 2019. e-Pub 2019.
11. Diao K, Swanick CW, Lei X, Xu Y, Shen Y, Smith GL, Giordano S, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes after Breast Conserving Therapy in Older Breast Cancer Survivors 105(1):S19-S20, 2019. e-Pub 2019.
12. White JR, Winter K, Cecchini RS, Vicini FA, Arthur DW, Kuske RR, Rabinovitch RA, Sehkon A, Khan AJ, Chmura SJ, Shaitelman SF, McCormick B, Julian TB, Rogers CL, Bear HD, Petersen IA, Gustafson GS, GrossheimJr LD, Mamounas E, Ganz PA. Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial 105(1):S3-S4, 2019. e-Pub 2019.
13. Stauder MC, Tereffe W, Shaitelman SF, Smith BD, Yeboa DN, Reed VK, Delclos ME, Ibrahim N, Raghavendra AS, Karuturi MS, Keyomarsi K, Tripathy D, Woodward WA. Toxicity of Radiation Therapy Given Concomitantly with Palbociclib for Metastatic Breast Carcinoma 105(1):E60-E60, 2019. e-Pub 2019.
14. Buszek SM, Lin HY, Bedrosian I, Tamirisa N, Babiera G, Shen Y, Shaitelman SF. Lumpectomy plus Endocrine Therapy or Irradiation in Women Age 70 Years or Older with Hormone Receptor-Positive Early Breast Cancer: An Analysis of the National Cancer Database 105(1):E16-E17, 2019. e-Pub 2019.
15. Pasalic D, Strom EA, Allen PK, Williamson T, Poenisch F, Amos RA, Woodward WA, Stauder, MC, Shaitelman SF, Smith BD, Perkins GH, Tereffe W, Hoffman KE. Prospectively Assessed Outcomes for Proton Accelerated Partial Breast Irradiation 105(1):S193-S193, 2019. e-Pub 2019.
16. BV Chapman DD Liu SR Stecklein A M Gutierrez Barrera WA Woodward G Sawakuchi BK Arun SF Shaitelman BV. Germline BRCA1/2 Mutation Status Is Not Associated with Differential Radiation Responsiveness in Patients with Locally Advanced Breast Cancer 105(1):S42-S43, 2019. e-Pub 2019.
17. Flint D, Bright S, McFadden C, Chakraborty S, Yoon D, Shaitelman S, Kodaira S, Konishi T, Sawakuchi G. BEST IN PHYSICS (THERAPY): The Nonhomologous End-Joining Repair Pathway Determines Cell Radiosensitivity in Helium and Carbon Ion Beams 46(6):E456-E457, 2019. e-Pub 2019.
18. Chapman BV, Liu DD, Stecklein SF, Gutierrez Barrera A, Woodward WA, Sawakuchi GO, Arun B, Shaitelman SF. Outcomes after adjuvant radiotherapy in breast cancer patients with and without germline mutations: A large, single-institutional experience 37(15):Suppl 1502, 2019. e-Pub 2019.
19. Singh P, Yi M, Gould R, Shaitelman S, Hunt K, Symmans WF, Bedrosian I. Association of a genomic index of sensitivity to endocrine therapy with locoregional recurrence of breast cancer 26:176-177, 2019. e-Pub 2019.
20. Chapman BV, Lei XD, Patil P, Tripathi S, Nicklaus K, Fingeret M, Shaitelman SF, Hunt K, Buchholz T, Merchant F, Markey M, Smith B, Reddy JP. Quantitative 3D Assessment of Breast Cosmesis After Conventional (CF-WBI) versus Hypofractionated Whole Breast Radiation (HF-WBI): Results of a Randomized Clinical Trial 103(5):E19-E19, 2019. e-Pub 2019.
21. Stecklein SR, Shaitelman SF. Re-Evaluating pCR in Women With Breast Cancer Post-Neoadjuvant Chemotherapy Reply 103(5):1281-1281, 2019. e-Pub 2019.
22. Pezzi TA, Ning MS, Thaker NG, Boyce-Fappiano D, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko S, Shaitelman SF, Chun SG, Tang C, Frank SJ, Nguyen QN Gomez DR. Evaluating Single-Institution Costs of Consolidative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer Using Time-Driven Activity-Based Costing 103(5), 2019. e-Pub 2019.
23. Vasmel J, Koerkamp MG, Kirby A, Russell N, Shaitelman S, Vesprini D, Anandadas C, Currey A, Keller B, Braunstein L, Han K, Kotte A, De Waard S, Philippens M, Houweling A, Verkooijen H, Van den Bongard D. Evaluation of MRI-based guidelines for contouring tumors for preoperative partial breast irradiation 133:S719-S719, 2019. e-Pub 2019.
24. Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzoDJ, Curran WJ, Wolmark N. Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304 79(4), 2019. e-Pub 2019.
25. Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Curran, Jr WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC), 2018. e-Pub 2018.
26. Shaitelman SF, Lei, XD, Thompson A, Schlembach P, Arzu I, Bloom ES, Buchholz, DJ, Chronowski GM, Dvorak T, Grade EJ, Hoffman KE, Kelly P, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Baumann D, Amaya D, Guerra W Morrison M, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Three-year outcomes with hypofractionated (HF) versus fractionated (CF) whole breast irradiation (WBI), 2018. e-Pub 2018.
27. Stecklein SR, Babiera GV, Bedrosian I, Shaitelman SF, Ballo MT, Tereffe W, Arzu IY, Perkins GH, Reed VK, Smith BD, Woodward, WA, Hoffman KE, Schlembach PJ, Chronowski GM, Shah SJ, Kirsner SM, Nelson CL, Guerra W, Dibaj SS, Bloom ES. Prospective comparison of late toxicity and cosmetic outcome after accelerated partial breast irradiation with conformal external beam radiotherapy or single-entry multi-lumen intracavitary brachytherapy 78(4), 2018. e-Pub 2018.
28. Grossberg A, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom E, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Prospective Validation of Transforming Growth Factor-Beta (TGF-beta) Polymorphism C509T as a Predictor of Radiation-Induced Fibrosis in Early Stage Breast Cancer Patients 99(5):P1318, 2017. e-Pub 2017.
29. Frank BD, Olivieri ND, Ghafar R, Calhoun J, Guzman A, De la Cerda I, Loggenberg A, Onwenu J, Sharma M, Shaitelman SF, Minsky BD, Jeter MD, Feeley T, Hahn SM. Time-Driven Activity-Based Costing (TDABC) in Radiation Oncology: A Method for Implementation 99(2):E395, 2017. e-Pub 2017.
30. Netherton T, Li Y, Nitsch PL, Gao S, Muruganandham M, Shaitelman SF, Frank SJ, Hahn SM, Balter P, Klopp AH, Court LE. Efficiency and Efficacy of Intensity Modulated Treatments on a Novel Linear Accelerator 99(2):E703, 2017. e-Pub 2017.
31. Stecklein SR, Park M, Liu DD, Valle JJ, Caudle AS, Mittendorf EA, Barcenas CH, Woodward WA, Valero V, Shaitelman SF. Impact of Regional Nodal Irradiation After Neoadjuvant Chemotherapy in Breast Cancer Patients with Cytologically Confirmed Axillary Lymph Node Metastases 99(2):E47-48, 2017. e-Pub 2017.
32. Sekhon A, Zhao R, Wang Y, Grant D, Winter KA, Moughan J, Douglas AW, Chmura SJ, Khan AJ, Shaitelman SF, Martinez AM, Vicini FA, White JR. Creating a Review Process of a Digital Photo Database Collected on NRG NSABP B39/RTOG 0413 Phase III Clinical Trial for Evaluation of Cosmetic Results from Breast Conserving Therapy (BCT), 2017. e-Pub 2017.
33. Van Wyhe RD, Shaitelman SF, Caudle AS, Hoffman KE, Perkins GH, Tereffe W, Smith BD, Strom EA, Buchholz TA, Woodward, WA, Stauder MC. Invasive Lobular Carcinoma Predicts for an Increased Likelihood of Surgical Upstaging Requiring Post-Mastectomy Radiation Therapy 98(2):E13, 2017. e-Pub 2017.
34. Christopherson KM, Lei X, Barcenas CH, Buchholz TA, Hoffman KE, Kuerer HM, Mittendorf EA, Perkins GH, Shaitelman SF, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Breast Cancer Patients Presenting with Sternal or Mediastinal Involvement 98(2):E1-2, 2017. e-Pub 2017.
35. Netherton T, Shaitelman S, Li Y, Nitsch P, Balter P, Gao S, Muruganandham M, Frank S, Hahn S, Klopp A, Court L. Multi-Isocenter Breast Treatments On a Prototype Linear Accelerator: A Study of Interplay Effect and Robustness, 2017. e-Pub 2017.
36. Netherton T, Li Y, Nitsch P, Balter P, Gao S, Muruganandham M, Shaitelman S, McCarroll R, Frank S, Hahn S, Klopp A, Court L. Efficiency and Efficacy of Intensity Modulated Treatments On a Prototype Linear Accelerator, 2017. e-Pub 2017.
37. Reddy JP, Lei XD, Patil P, Nicklaus KM, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD. Using Quantitative 3D Metrics of Breast Cosmesis to Compare Fractionation Regimens for Whole Breast Irradiation 98(2):E2, 2017. e-Pub 2017.
38. Christopherson KM, Lei X, Barcenas CH, Buchholz TA, Hoffman KE, Kuerer HM, Mittendorf EA, Perkins GH, Shaitelman SF, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward WA, Smith BD. Curative-Intent Treatment for Newly Diagnosed Breast Cancer With Limited Metastatic Disease to the Sternum or Mediastinum, 2017. e-Pub 2017.
39. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kornowitz S. Radiotherapy After Skin-Sparing Mastectomy and Placement of a Tissue Expander: Effectiveness of a Coordinated, Multidisciplinary Approach 98(2):E19, 2017. e-Pub 2017.
40. Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini F, Ganz PA McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Curran WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC), 2017. e-Pub 2017.
41. Olivieri ND, Frank BD, Calhoun JD, Guzman AB, Onwenu JN, De La Cerda I, Sharma M, Loggenberg A, Shaitelman SF, Minsky BD, Jeter M, Ghafar R, Feeley TW, Hahn SM. Measuring cost in the value equation using time-driven activity-based costing (TDABC) at The University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, 2017. e-Pub 2017.
42. EP Mamounas EP, H Bandos H, JR White JR, TB Julian TB, AJ Khan AJ, SF Shaitelman SF, MA Torres MA, FA Vicini FA, PA Ganz PA, SA McCloskey SA, S Paik S, N Gupta N, XA Li XA, DJ DiCostanzo DJ, WJ Curran Jr WJ, N Wolmark N. NRG oncology/NSABP B-51/RTOG 1304: A phase III superiority clinical trial designed to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes and convert to ypN0 after neoadjuvant chemotherapy (NC), 2017. e-Pub 2017.
43. CW Swanick CW, X Lei X, Y Xu Y, Y Shen Y, NA Goodwin NA, SH Giordano SH, KK Hunt KK, R Jagsi R, S Shaitelman S, SK Peterson SK, BD Smith BD. Patient-reported cosmetic outcomes in older breast cancer survivors: A population-based survey study, 2017. e-Pub 2017.
44. Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Giordano SH, Hunt KK, Pusic AL, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Population-Based Assessment of Patient-Reported Cosmetic Outcomes in Older Breast Cancer Survivors, 2016. e-Pub 2016.
45. Cai CY, Calhoun JD, Kanke J, Melancon AD, Collado D, Gifford K, Semien K, Potocsny N, Stauder MC, Guzman AB, Randolph CL, Sobremonte A, Marsh GD, Woodward WA, Feeley TW, Shaitelman SF. Defining Cost as a First Step to Determining the Value of Radiation Services Provided: Utilizing Time-Driven Activity-Based Costing to Ascertain True Costs in Breast Cancer Radiation Treatment Planning, 2016. e-Pub 2016.
46. Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret M, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak T, Buchholz TA, Smith BD. Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation, 2016. e-Pub 2016.
47. Shaitelman SF, Stauder MC, Allen PK, Reddy S, Lakoski SG, Atkinson BJ, Moulder S, Reddy J, Amaya D, Guerra W, Ueno NT, Caudle AS, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple-Negative Breast Cancer, 2016. e-Pub 2016.
48. Reddy J, Lei X, Huang H, Nicklaus KM, Fingeret M, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD. Using Quantitative Metrics of Breast Cosmesis to Compare Fractionation Regimens for Whole- Breast Irradiation, 2016. e-Pub 2016.
49. Moreno AC, Lin H, Bedrosian I, Smith BD, Babiera G, Stauder MC, Buchholz TA, Woodward WA, Shen Y, Shaitelman SF. Effect of Regional Nodal Irradiation on Overall Survival in Patients With High-risk Invasive Breast Cancer: A National Cancer Data Base Analysis, 2016. e-Pub 2016.
50. Mamounas ER, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini F, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Curran, Jr WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC), 2016. e-Pub 2016.
51. Mamounas EP, Bandos H, White JR, Julian TB, Khan TJ, Shaitelman SF, Torres MA, Vicini F, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Costantino JP, Curran WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC) 34(15_suppl):TPS 1097, 2016. e-Pub 2016.
52. Colfry J, Lin H, Shen Y, Kuerer H, Shatielman S, Babiera G, Bedrosian I. Patterns of axillary surgery in DCIS patients within the US National Cancer Database, 2016. e-Pub 2016.
53. Shaitelman SF, Ferguson SE, DeSnyder SM, Kheirkhah P, Lilly S, Travis M, Johnson T, Alvarez A, Rohe E, Buchholz TA, Bedrosian I. Initiating a lymphedema screening program for breast cancer patients: Determining variability as a first step towards standardization 34(7_suppl):267, 2016. e-Pub 2016.
54. Smith BD, Jiang J, Y-CT S, Giordano SH, Huo J, Jagsi R, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Complication and economic burden of local therapy options for early breast cancer, 2016. e-Pub 2016.
55. Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Paik S, Gupta N, Li XA, DiCostanzo DJ, Costantino JP, Curran WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: A phase Ill clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypNO after neoadjuvant chemotherapy (NC), 2016. e-Pub 2016.
56. Alvarez RH, Koenig KB, Ensor JE, Ibrahim NK, Chavez-MacGregor M, Litton JK, Schwartz Gomez JK, Cyriac A, Krishnamurty S, Caudle AS, Shaitelman SF, Whitman GJ, Booser DJ, Reuben JM, Valero V. A randomized phase II neoadjuvant (NACT) study of sequential eribulin followed by FAC/FEC-regimen compared to sequential paclitaxel followed by FAC/FEC-regimen in patients (pts) with operable breast cancer not overexpressing HER-, 2016. e-Pub 2016.
57. Pan HY, Edwards TJ, Giragosian DP, Holliday EB, Swanick CW, Martin GV, Hoffman KE, Shaitelman SF, Woodward WA, Smith BD. Improving clinical documentation and prospectively populating a research database using an electronic data capture system for routine clinical care 93(3):E386, 2015. e-Pub 2015.
58. Lin HY, Babiera G, Bedrosian I, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen Y. Factors influencing treatment of inflammatory breast cancer in the United States 33(28_suppl):118, 2015. e-Pub 2015.
59. Vila J, Bassett RL, Mittendorf EA, Bedrosian I, Shaitelman SF, Stauder MC, Chavez-MacGregor M, Litton JK, Yang WT, Huo L, Kuerer HM, Hunt K, Caudle AS. A nomogram to predict axillary response to neoadjuvant chemotherapy in clinically node positive breast cancer 33(suppl, abstr 1034), 2015. e-Pub 2015.
60. Mamounas EP, Bandos H, White JR, Julian TB, Kahn AJ, Shaitelman SF, Torres MA, McCloskey SA, Vicini FA, Ganz PA, Paik S, Gupta N, Costantino JP, Curran Jr WJ, Wolmark N. NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC) 33(15_suppl):TPS11112, 2015. e-Pub 2015.
61. Walker GV, Grant SR, Shaitelman SF, Klopp AH, Frank SJ, Pugh TJ, Allen PK, Mahmood U. Variation and impact of insurance status among non-elderly cancer patients who are potential candidates for prostate, breast, or GYN brachytherapy, 2015. e-Pub 2015.
62. Loveland-Jones, C, Shaitelman S, Lin H, Shen Y, Bedrosian I, Kuerer HM, Babiera G. Disparities in the use of post-mastectomy radiation therapy for inflammatory breast cancer, 2015. e-Pub 2015.
63. Colfry AJ, Lin H, Shen Y, Kuerer HM, Shaitelman S, Babiera G, Bedrosian I. Factors associated with DCIS diagnosis: a population based review of the National Cancer Database, 2015. e-Pub 2015.
64. Stauder MC, Shaitelman SF, Allen PK, Brewster AM, Arun BK, Woodward WA, Buchholz TA, Wang L. Gamma-ray induced mutagen sensitivity and overall survival in young women with breast cancer, 2014. e-Pub 2014.
65. Shaitelman SF, Buchholz TA, Hunt KK, Hortobagyi GN, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, Grade E, Hoffman KE, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breast irradiation: results of a randomized trial 90(5):1264, 2014. e-Pub 2014.
66. Ovalle V, Strom EA, Godby J, Shaitelman SF, Kuerer HM, Woodward WA, Hoffman KE. Proton accelerated partial breast irradiation for early stage breast cancer: a not-so-costly alternative, 2014. e-Pub 2014.
67. Shaitelman SF, Tereffe W, Hess KR, Gonzalez-Angulo AM, Dogan BE, Stauder MC, Valero V, Krishnamurthy S, Strom EA, Hunt KK, Buchholz TA, Whitman GJ. The role of ultrasound of the regional nodal basin in staging patients with triple negative breast cancer: implications for local-regional treatment 90(1):S172, 2014. e-Pub 2014.
68. Stauder MS, Shaitelman SF, Allen PK, Smith BD, Hoffman KE, Buchholz TA, Middleton LP, Chavez-Macgregor M, Caudle AS, Hunt KK, Meric-Bernstam F, Woodward WA. Postmastectomy radiation therapy after positive sentinel lymph node biopsy and completion axillary lymph node dissection 90(1):S235-S236, 2014. e-Pub 2014.
69. Howell RM, Tereffe W, Stauder MC, Stingo F, Strom EA, Perkins GH, Smith BD, Woodward WA, Hoffman KE, Buchholz TA, Salehpour MR, Kry SF, Barcenas CH, Yusuf WS, Shaitelman SF. Toward developing survivorship care plans for breast cancer patients at high risk for radiation-related cardiac effects 90(1):S857-S858, 2014. e-Pub 2014.
70. Lautner MA, Lin HY, Shen Y, Parker C, Kuerer HM, Shaitelman SF, Babiera G, Bedorian I. Disparities in utilization of breast-conserving therapy among breast cancer patients 32(26):S104, 2014. e-Pub 2014.
71. Shaitelman SF, Cromwell KD, Chiang YJ, DeSnyder SM, Skoracki RJ, Cormier JN. Radiation Targets and the Development of Breast Cancer-Related Lymphedema: A Systematic Review of the Literature, 2014. e-Pub 2014.
72. Parker C, Lin HY, Shen Y, Li L, Lautner MA, Kuerer KM, Shaitelman SF, Babiera G, Bedrosian I. Effect of hormone receptor status and local treatment on overall survival for early-stage breast cancer 32(26):S60, 2014. e-Pub 2014.
73. Strom EA, Amos RA, Shaitelman S, Kerr M, Hoffman K, Smith BD, Amin M, Wang X, Poenisch F, Woodward WA. Prospective phase 2 proton APBI: multibeam supine treatment is reproducible and free from acute toxicity 90(1):S201-S202, 2014. e-Pub 2014.
74. Wobb J, Chen PY, Shah C, Moran MS, Shaitelman SF, Vicini FA, Mbah AK, Lyden M, Beitsch PD. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation 32(26):S59, 2014. e-Pub 2014.
75. Leif J, Nguyen H, Hollan A, Followill D, Galvin J, Kiniry D, Julian TB, Mamounas EP, White J, Kahn AJ, Shaitelman S, Torres M, Vicini F, Wolmark N, Curran WJ. The credentialing process for the NSABP B-51/RTOG 1304 phase 3 randomized clinical trial 90(1):S940, 2014. e-Pub 2014.
76. Peterson IA, Mayo CM, Shaitelman SF, Yan ES, Martel MK, Park SS, Woodward WA, Mutter RW, Howell RM. What is normal? Cooperative pooled database to establish typical heart and lung doses for modern breast radiation therapy 90(1):S263-S264, 2014. e-Pub 2014.
77. Mamounas EP, White JR, Bandos H, Julian TB, Kahn AJ, Shaitelman SF, Torres MA, McCloskey SA, Vicini FA, Ganz PA, Paik S, Gupta N, Costantino JP, Curran WJ, Wolmark N. NSABP B-51/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC 32(15):TPS1141, 2014. e-Pub 2014.
78. Lautner M, Parker C, Lin H, Shen Y, Kuerer H, Shaitelman S, Babiera G, Bedrosian I. National trends in mastectomy rates from 1998 to 2010, 2014. e-Pub 2014.
79. Rueth NM, Lin HY, Bedrosian I, Shaitelman SF, Ueno NT, Shen Y, Babiera G. Underuse of tri-modality therapy impacts survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database, 2014. e-Pub 2014.
80. Shen MC, Bloom E, Shaitelman SF, Wei C, Haynes AB, Mittendorf EA, Kuerer HM, Bedrosian I, Hwang RF, Hunt KK, Tereffe W, Strom E, Babiera GV. Comparison of infectious complications between breast conserving therapy with catheter-based accelerated partial breast irradiation and whole breast irradiation, 2013. e-Pub 2013.
81. Shaitelman SF. Utilization of accelerated partial-breast irradiation and guideline concordance: Analysis of the National Cancer Database 31(26):S54, 2013. e-Pub 2013.
82. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of infectious complications following breast conserving therapy with catheter-based accelerated partial bresat irradiation, 2012. e-Pub 2012.
83. Johnson M, Mangona VS, Yan D, Shaitelman SF, Kestin LL, Wloch JB, Martin SK, Ye H, Kreofsky C, Grills IS. Survival and toxicity after standard dose 3-D conformal radiation therapy or high-dose intensity modulated radiation therapy for locally advanced non-small cell lung cancer 84(3):S607-S608, 2012. e-Pub 2012.
84. Wilkinson JB, Beitsch PD, Arthur DW, Shah C, Haffty BG, Wazer DE, Keisch M, Shaitelman SF, Lyden M, Vicini F. Evaluation of current consensus panel guidelines for APBI: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeons MammoSite registry trial data 30(27):S145, 2012. e-Pub 2012.
85. Shaitelman SF, Vicini FA, Beitsch PD, Keisch M, Arthur DW, Lyden M. Time to revise the consensus statement guidelines for the use of accelerated partial breast irradiation off protocol? 81(2):S204, 2011. e-Pub 2011.
86. Wilkinson JB, Shah C, Amin M, Shaitelman SF, Nadeau L, Chen P, Wallace M, Mitchell C, Grills IS, Martinez AA, Vicini FA. Outcomes by breast cancer subtype in patients treated with accelerated partial breast irradiation 29(27):S83, 2011. e-Pub 2011.
87. Shaitelman SF, Grills IS, Kestin LL, Ye H, Nandalur S, Huang J, Vicini FA. Equivalent incidence of second malignancies after definitive treatment for ductal carcinoma in situ: a matched pair analysis of surgery and radiation versus surgery alone, 2010. e-Pub 2010.
88. Shaitelman SF, Kim LH, Yan D, Martinez AA, Vicini FA, Grills IS. Continuous arc rotation of the couch: an accelerated partial breast irradiation planning study, 2010. e-Pub 2010.
89. Shaitelman SF, Kestin LL, Ye H, Ghilezan MI, Gustafson GS, Krauss DJ, Marvin K, Martinez AA. Chronic toxicity profile of high dose rate brachytherapy (HDR-BT) boost with pelvic external beam radiation therapy (P-EBRT) for intermediate- and high-risk prostate cancer, 2010. e-Pub 2010.
90. Sohn M, Shaitelmen S, Kestin L, Grills I, Liang J, Alber M, Yan D. V20, VX, EUD or mean dose: determining the best predictor for development of radiation pneumonitis comparing different NTCP-models, 2010. e-Pub 2010.
91. Kim LH, Shaitelman SF, Grills IS, Vicini FA, Martinez AA, Yan D. Is the 1 cm CTV margin used in breast balloon brachytherapy equivalent to a 1.5 cm CTV margin in external beam partial breast irradiation: A deformable registration study 78(3):S234, 2010. e-Pub 2010.
92. Shaitelman SF, Kim LH, Grills IS, Chen PY, Ye H, Kestin LL, Yan D, Vicini FA. Acceptable long-term toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation, 2010. e-Pub 2010.
93. Mancini B, Kim LH, Shaitelman SF, Yan D, Kestin LL, Grills IS. Intensity-modulated radiation therapy (IMRT) or volumetric modulated radiation therapy (VMAT) to reduce the incidence of alopecia, xerostomia, and otitis following whole brain radiation therapy for brain metastases: A treatment planning analysis 78(3):S840, 2010. e-Pub 2010.
94. Shaitelman SF, Kestin LL, Ye H, Ghilezan MI, Gustafson GS, Krauss DJ, Marvin K, Martinez AA. Chronic toxicity profile of hypofractionated, high dose rate brachytherapy boost with pelvic external beam radiation therapy for intermediate- and high-risk prostate cancer 9(S30), 2010. e-Pub 2010.
95. Dilworth J, Hurst NJ, Chen PY, Shaitelman SF, Baschnagel A, Ye H, Maitz A, Krauss DJ, Pieper DR, Grills IS. Outcomes of patients with resected metastatic brain lesions treated with gamma knife or whole brain irradiation 78(3):S288, 2010. e-Pub 2010.
96. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M. Five-year outcome of patients classified using the American Society for Radiation Oncology (ASTRO) consensus statement (CS) guidelines for the application of accelerated partial breast irradiation (APBI): an analysis of patients treated on the American Society of Breast Surgeons (ASBS) MammoSite Registry Trial 78(3):S229, 2010. e-Pub 2010.
97. Wilkinson JB, Wallace M, Chen PY, Mitchell C, Shaitelman SF, Marvin K, Grills IS, Vicini FA. Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation 78(3):S234, 2010. e-Pub 2010.
98. McInerney E, Shaitelman SF, Grills IS, Kestin LL, Ye H, Nandalur S, Huang J, Vicini FA. Equivalent incidence of second malignancies after definitive treatment for ductal carcinoma in situ: a matched pair analysis of surgery and radiation vs. surgery alone 78(3):S51-S52, 2010. e-Pub 2010.
99. Chen PY, Shaitelman SF, Kim LH, Grills IS, Ye H, Vicini F. Predictors of long term toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation 78(3):S219, 2010. e-Pub 2010.
100. Liu T, Woodhouse SA, Shaitelman SF, Zhou J, Wong TJ, Yoshida EJ, Kutcher GJ, Curran WJ. Preliminary demonstration of a radiation-dose response via ultrasound-based skin measurements in breast cancer radiotherapy 75(3):S192, 2009. e-Pub 2009.
101. Shaitelman SF, Grills SF, Liang J, Zhuang L, Mangona V, Yan D, Kestin LL. A comprehensive dose-volume analysis of predictors of pneumonitis and esophagitis following radiotherapy for non-small cell lung cancer 75(3):S468, 2009. e-Pub 2009.
102. Deutsch SF, Simon SR, Fletcher RF, Peters AS. Fourth-year medical students’ practice of evidence-based medicine, 2005. e-Pub 2005.
103. Deutsch, SF. Mental health services at colleges and universities: A brief history, 2005. e-Pub 2005.
104. Deutsch SF. Medical education: An American perspective, 2005. e-Pub 2005.
105. Deutsch SF. Advice from the field: How to design a medical school international health project, 2002. e-Pub 2002.
106. Aldrich MB, McWain ME, Chan W, Rasmussen JC, DeSnyder S, Sevick-Muraca EM, Shaitelman SF. Arm lymphatic pulsing changes after mastectomy or breast-conserving surgery with axillary lymph node dissection, detected with near-infrared fluorescence lymphatic imaging 2022(82 (4_Supplement)):P4-11-18.
107. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A ten-year experience with mastectomy and tissue expander placement to facilitate subsequent radiation and reconstruction.
108. Shaitelman SF, Sevick-Muraca EM, Chan W, Rasmussen JC, DeSnyder S, Aldrich MB. Dermal backflow, detected by near-infrared fluorescence lymphatic imaging, is a very accurate early prognostic of breast cancer-related lymphedema development.
109. Nat P, Wenyaw C, Simona S, Sevick-Muraca Eva M, Aldrich Melissa B. A plasma cytokine profile for early detection of lymphedema.

Book Chapters

1. Stecklein SR. Locally Advanced Breast Cancer. In: Radiation Oncology A Question-Based Review. Wolters Kluwer, 2019.
2. Colbert L. Early Stage (I-II) Breast Cancer. In: Radiation Oncology A Question-Based Review. Wolters Kluwer, 2019.
3. Fang P. Ductal and Lobular Carcinoma in Situ. In: Radiation Oncology A Question-Based Review. Wolters Kluwer, 2019.
4. Stecklein SR. General Breast Cancer. In: Radiation Oncology A Question-Based Review. Wolters Kluwer, 2019.
5. DeSnyder SM, Shaitelman SF, Schaverien MV. Lymphedema and Body Image Disturbance. In: Body Image Care for Cancer Patients, Principles and Practice. Oxford, 2018.
6. Shaitelman SF, Shah C, Kim LH, Vicini FA, Arthur DW, Khan AJ. Breast Brachytherapy. In: Brachytherapy: Applications and Techniques. 2nd. Wolters Kluwer Health, 165-185, 2016.
7. Shaitelman SF. Careers in Medical Education. In: Physicians' Pathways to Non-Traditional Cancers and Leadership Opportunities. Springer, 2011.
8. DeSnyder SM, Shaitelman SF. Rehabilitation and management of lymphedema in patients with breast cancer. In: Breast Cancer, 3rd Ed.

Letters to the Editor

1. Shaitelman, SF, Cabrera, AR, May, KS, Lyons, J. In Reply to Fastner et al. Practical radiation oncology 15: 50-53, 2025.
2. Shaitelman, SF, Cabrera, AR, May, KS, Lyons, J. In Reply to Kaidar-Person et al. Practical radiation oncology 14: e532-e533, 2024.
3. Kim L, Shaitelman S. What is the target volume for preoperative accelerated partial breast irradiation (APBI)? In regards to Nichols et al. (Int J Radiat Oncol Biol Phys 2010;77:197-202) and Palta et al. (Int J Radiat Oncol Biol Phys 2010, in Press). Int J Radiat Oncol Biol Phys 80: 314-5; author reply 315-6, 2011.